General

The Power Of The Pivot – Lessons from the biotech frontline

Back People Not Projects

By Ian Nisbet*

“If plan A doesn’t work, the alphabet has 25 more letters – 46 if you’re in Japan.” (Claire Cook, Seven Year Switch)

In the late 1980s and early 1990s I was working at CSL during the years leading up to its public listing and prior to it becoming the behemoth it […]

2020-11-19T01:14:44+00:00November 19th, 2020|

The Fight Against Cancer Continues ……. Despite COVID-19

18 November 2020

By Leigh Dayton

They may not be able to gather at the Melbourne Convention Centre this year, but global experts in immunotherapy will swap ideas December 15 & 16 as Eradicate Cancer 2020 goes virtual.

Taking on the role of conference convenor for the second time, after the highly successful inaugural Conference in 2018, […]

2020-11-18T05:46:21+00:00November 18th, 2020|

Cartherics CEO handed the editorial chair

Alan Trounson guest edits a special immunology issue of the journal Cells

 By Leigh Dayton 9 Nov 2020

 

As well as steering the Melbourne-based biotech company through the challenges of COVID-19, CEO Alan Trounson has taken up the role of guest editor for the prestigious journal Cells.

It’s a perfect match. The journal’s upcoming special issue will […]

2020-11-09T04:59:01+00:00November 9th, 2020|

Nobel Chemistry prize going to CRISPR scientists

Genetic scissors: a tool for rewriting the code of life wins the 2020 Nobel Prize for Chemistry

Emmanuelle Charpentier and Jennifer A. Doudna have discovered one of gene technology’s sharpest tools: the CRISPR/Cas9 genetic scissors.

The Royal Swedish Academy of Sciences

7 October 2020

Using these tools, researchers can change the DNA of animals, plants and microorganisms with […]

2020-10-09T23:54:50+00:00October 9th, 2020|

Good news from Cartherics. The company’s off-the-shelf immune therapy for ovarian cancer is close to clinical trials

View the article in the CRC (Cooperative Research Centres Association) Association Newsletter here : CRC Association Newsletter

Cartherics’ cost-effective ‘off-the-shelf’ ovarian cancer therapy made from special donor umbilical cord blood samples is in the final stages of preclinical development.

By combining immunotherapy and stem cell research, we can manufacture Natural Killer (NK) cells that carry a […]

2020-09-23T05:36:40+00:00September 23rd, 2020|

Frustrated by Victoria’s COVID-19 Lockdown? Try India ……

That’s where Anisha Balachandran – Cartherics’ past PhD student has been since January

22 September 2020

Finally, Anisha is back, well almost. She is currently in lockdown in Sydney. While there, she spoke with Cartherics Communication’s Advisor Leigh Dayton about her experience.

When and why did you go to India?

My dad passed away due to a cardiac arrest […]

2020-09-22T06:41:02+00:00September 22nd, 2020|

Cartherics CEO Alan Trounson celebrates 40 years of the GSK Award for Excellence

Along with others Alan shares his experience in this short clip  ………

 

 

 

2020-09-08T02:41:33+00:00September 8th, 2020|

From waging war with elusive pathogens to tackling cancer

Cartherics’ newest recruit, Phil Arandjelovic loves it all

By Leigh Dayton

In his application for Cartherics’ Research Scientist position, Phil noted: “I am an independent and hard-working research scientist who is proficient at working both individually and with a team”. True.

What Phil failed to mention is that he loves a good conversation. Politics, mentoring, economics and, of […]

2020-09-07T05:26:42+00:00September 7th, 2020|

The answer to self-discovery is found at Cartherics

For new recruit Walid Azar, it was about finding his calling.

 As Walid Azar settles into his new dual role as Senior Research Fellow and Deputy Lab Manager at Cartherics, he feels content that he has finally found his calling. With previous experience in both cancer research and industry, he acknowledges having lived in the best […]

2020-09-02T02:45:37+00:00September 2nd, 2020|

‘Chance favours the prepared mind’

Frederico Calhabeu has followed Louis Pasteur’s advice from France to Cartherics

By Leigh Dayton

When considering whether to continue his translational research program at the Australian Regenerative Medicine Institute (ARMI), Frederico Calhabeu had a quick chat with Silvio Tiziani, Director, External Strategy and Planning at ARMI.

Silvio suggested a quiet word with several contacts in the […]

2020-08-27T00:48:45+00:00August 27th, 2020|